Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease ‡

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 3, 1996, Pages 208-215

  Azer, Samy A ^a   Coverdale, Shirley A ^b   Byth, Karen ^b   Farrell, Geoffrey C ^b   Stacey, Neill H ^a  

^a National Institute of Occupational Health and Safety   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Child Turcotte and Mayo scores; Chronic cholestatic liver disease; Individual serum bile acids; Liver transplantation; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

CHENODEOXYCHOLIC ACID; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LIVER TRANSPLANTATION; MALE; PREDICTION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0029879867     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00064.x     Document Type: Article

References (46)

1. Wiesner RH, Porayko MK, Dickson ER et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1992; 16: 1290-9.
2. Martin M. Primary sclerosing cholangitis. Annu. Rev. Med. 1993; 44: 221-7.
3. Turcotte JG, Wallin VW Jr, Child CG III. End-to-side versus side-to-side portocaval shunt in patients with hepatic cirrhosis. Am. J. Surg. 1969; 117: 108-16.
4. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
5. Dickson ER, Grambsch PM, Fleming TR, Fischer LD, Langworthy A. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989; 10: 1-7.
6. Wiesner RH, Grambsch PM, Dickson ER et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-6.
7. Klion FM, Fabry TL, Palmer M, Schaffner F. Prediction of survival of patients with primary biliary cirrhosis. Examination of the Mayo clinic model on a group of patients with known endpoint. Gastroenterology 1992; 102: 310-13.
8. Goudie BM, Burt AD, Macfarlane GJ et al. Risk factors and prognosis in primary biliary cirrhosis. Am. J. Gastroenterol. 1989; 84: 713-16.
9. Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand. J. Gastroenterol. 1990; 25: 119-26.
10. Westaby D, McDougall BRD, Williams R. Improved survival following injection sclerotherapy for esophageal varices: Final analysis of a control trial. Hepatology 1985; 5: 827-30.
11. Hartmann AH, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand. J. Gastroenterol. 1989; 24: 269-76.
12. Conn HO. A peak at the Child-Turcotte classification. Hepatology 1981; 1: 673-6.
13. Christensen E, Schlichting P, Fauerholdt L et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4: 430-5.
14. Barbare JC, Poupon RE, Jaillon P, Prod'homme S, Darnis F, Poupon RY. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis. J. Hepatol. 1985; 1: 253-9.
15. Reichen J, Widmer T, Cotting J. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: A comparison with the Mayo model. Hepatology 1991; 14: 504-10.
16. Christensen E. Prognostication in primary biliary cirrhosis: Relevance to the individual patients. Hepatology 1989; 10: 111-13.
17. Neuberger JM, Gunson BK, Buckels JAC, Elias E, McMaster P. Referral of patients with primary biliary cirrhosis for liver transplantation. Gut 1990; 31: 1069-72.
18. Azer SA, Murray M, Farrell GC, Stacey NH. Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats. Hepatology 1993; 18: 1224-31.
19. Mannes GA, Stellaard F, Paumgartner G. Diagnostic sensitivity of fasting and postprandial serum bile acids determination by different methods. Clin. Chim. Acta 1987; 162: 147-54.
20. 99mTc]-EHIDA and serum bile acid levels in liver function and disease. Dig. Dis. Sci. 1992; 37: 1655-60.
21. Mannes GA, Thieme C, Stellaard F, Wang T, Sauerbruch T, Paumgartner G. Prognostic significance of serum bile acids in cirrhosis. Hepatology 1986; 6: 50-3.
22. Siciliano M, Barbesino G, Marra L, Milani A, Rossi L. Long-term prognostic value of serum bile acids in liver cirrhosis: A prospective study. Z. Gastroenterol. 1989; 27: 653-6.
23. Poupon RE, Chretien Y, Poupon R, Paumgartner G. Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy. Hepatology 1993; 17: 599-604.
24. Crosingnani A, Podda M, Battezzati PM et al. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991; 14: 1000-7.
25. Mazzella G, Parini P, Bazzoli F et al. Effect of ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Dig. Dis. Sci. 1993; 38: 896-902.
26. Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992; 15: 603-8.
27. Coverdale SA, Liddle C, Batey RG, Farrell GC. Sequential use of quantitative liver function tests: Do they provide novel information about the cause of nonalcoholic chronic liver disease. Aust. N.Z. J. Med. 1990; 20: 361 (Abstract).
28. Christensen E, Crowe J, Doniach D et al. Clinical pattern and course of disease in primary biliary cirrhosis based on analysis of 236 patients. Gastroenterology 1980; 78: 236-46.
29. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980; 79: 200-6.
30. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Primary sclerosing cholangitis. N. Engl. J. Med. 1984; 310: 899-903.
31. Wang G, Stacey NH, Earl J. Determination of individual bile acids in serum by high performance liquid chromatography. Biomed. Chromatogr. 1990; 4: 136-40.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-81.
33. Cox DR. Regression models and life tables. J. R. Stat. Soc. 1972; 34: 187-202.
34. Child CG III, Turcotte JG. Surgery and portal hypertension. In: Child CG III, ed. The Liver and Portal Hypertension. Philadelphia: Saunders, 1964; 1-85.
35. DeBruijne JJ, Rothuizen J. The value of serum bile acid and GLDH in the screening for canine liver function disorders. In: Blackmor DJ, Eckersall PD, Evans GD, Sommer H, Stonard MD, Woodman DD, eds. Animal Clinical Biochemistry: The Future. Cambridge: Cambridge University Press, 1988; 175-80.
36. Bloomer JR, Allen RM, Klatskin G. Serum bile acids in primary biliary cirrhosis. Arch. Intern. Med. 1976; 136: 57-61.
37. Stiehl A, Rudolph G, Raedsch R et al. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 1989; 12: 492-7.
38. Hayashi H, Higuchi T, Ichimiya H, Hishida N, Sakamoto N. Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. Gastroenterology 1990; 99: 533-5.
39. Hofmann AF, Popper H. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 1987; ii: 398-9.
40. Berry W, Reichen J. Bile acid metabolism: Its relation to clinical disease. Semin. Liver Dis. 1983; 3: 330-40.
41. Azer SA, Stacey NH. Effect of cyclosporin A in vivo on taurocholate uptake by rat hepatocytes. Biochem. Pharmacol. 1991; 42: 2053-7.
42. Driscoll TR, Hamdan HH, Wang G, Wright PFA, Stacey NH. Concentrations of individual bile acids in workers exposed to chlorinated aliphatic hydrocarbons. Br. J. Ind. Med. 1992; 49: 700-5.
43. Changbumrung S, Tungtrongchitr R, Migasena P, Chamroenngan S. Serum unconjugated primary and secondary bile acids in patients with cholangio-carcinoma, hepatocellular carcinoma. J. Med. Assoc. Thai. 1990; 73: 81-90.
44. Pennington CR, Ross PE, Bouchier AD. Serum bile acids in the diagnosis of hepatobiliary disease. Gut 1977; 18: 903-8.
45. McCormick WC III, Bell CC Jr, Swell L, Vlahcevic ZR. Cholic acid synthesis as an index of the severity of liver disease in man. Gut 1973; 14: 895-902.
46. Ejderhamn J, Strandvik B. Serum bile acids in relation to disease activity and intake of dietary fibers in juvenile ulcerative colitis. Digestion 1991; 50: 162-9.